150 DOLLARS TO CASH APP:$docnorm
NORMAN J CLEMENT RPH., DDS, NORMAN L.CLEMENT PHARM-TECH, MALACHI F. MACKANDAL PHARMD, BELINDA BROWN-PARKER, IN THE SPIRIT OF JOSEPH SOLVO ESQ., INC.T. SPIRIT OF REV. C.T. VIVIAN, JELANI ZIMBABWE CLEMENT, BS., MBA., IN THE SPIRIT OF THE HON. PATRICE LUMUMBA, IN THE SPIRIT OF ERLIN CLEMENT SR., WALTER F. WRENN III., MD., JULIE KILLINGWORTH, LESLY POMPY MD., CHRISTOPHER RUSSO, MD., NANCY SEEFELDT, WILLIE GUINYARD BS., JOSEPH WEBSTER MD., MBA, BEVERLY C. PRINCE MD., FACS., NEIL ARNAND, MD., RICHARD KAUL, MD., LEROY BAYLOR, JAY K. JOSHI MD., MBA, ADRIENNE EDMUNDSON, ESTER HYATT PH.D., WALTER L. SMITH BS., IN THE SPIRIT OF BRAHM FISHER ESQ., MICHELE ALEXANDER MD., CUDJOE WILDING BS, MARTIN NJOKU, BS., RPH., IN THE SPIRIT OF DEBRA LYNN SHEPHERD, BERES E. MUSCHETT, STRATEGIC ADVISORS
“WE ARE NOT POWERLESS AND THROUGH OUR VIDEOS, WRITINGS, AND PHOTOGRAPHS WE WILL EXPOSE THE ABUSES AND TYRANNY OF UNITED STATES DRUG ENFORCEMENT AGENCY
JUST AS THE VIDEO WAS RECORDED BY THE CELL PHONE CAMERA OF YOUNG DARNELLA FRAZIER, BORE WITNESS TO THE MURDER OF GEORGE FLOYD THE BLOG youarewithinthenorms.com BARES WITNESS AND BOTH ALLOWS THE SYSTEM TO BE HELD ACCOUNTABLE”
THE BACKING OF JUNK SCIENCE
RICHARD LAWHERN WRITES:
“As written, the draft guideline repeatedly admonishes doctors to perform a “risk versus benefits” analysis when first considering prescription opioids and any time increases in dose are contemplated.
But buried deeply in the document where few non-lawyers will read it is an explicit acknowledgment that there are no validated patient profiling tools for reliably accomplishing such an analysis.
Moreover, the draft continues to assert that non-opioid therapies are “preferable” to opioids — despite the fact that an exhaustive review of the literature reveals no trials of such non-opioid therapies as replacements for opioids. Seven out of twelve CDC recommendations are identified as “Category A” — applicable to almost all patients by all doctors — despite being founded upon very weak research evidence.”
WARNING DANGER, DANGER, DANGER WHAT WE NEED TO KNOW ABOUT NSAIDS AND THEIR LONG TERM USE
Sebastian Rushworth M.D. has published:
” Non-steroidal anti-inflammatory drugs (NSAID’s) have been around for a long time. Aspirin was invented in the 1890’s, and ibuprofen has been around since the early 1960’s. One problem with these drugs, which has been recognized since the early days, is that they can cause stomach ulcers. In fact, over-use of NSAID’s is one of the most common reasons for emergency hospital admissions due to bleeding ulcers.
The reason for this side-effect is that NSAID’s block an enzyme called cyclo-oxygenase, generally shortened to just COX (another name for NSAID’s is COX-inhibitors). There are two different versions of COX, COX-1, and COX-2. All the early NSAID’s are unselective COX-inhibitors. In other words, they block both COX-1 and COX-2.
At some point it was discovered that the entire positive effect that comes from NSAID’s, in terms of decreasing inflammation and pain, comes from their inhibition of COX-2, while inhibition of COX-1 is responsible for the side effect of increased bleeding. This naturally led drug companies to seek to develop specific COX-2 inhibitors, that would decrease inflammation, but not cause stomach ulcers.
In 1999, the first two COX-2 selective inhibitors came on the market, rofecoxib (a.k.a. Vioxx), produced by Merck, and celecoxib (a.k.a. Celebrex), produced by Pfizer. They instantly become some of the best-selling drugs in the world. Of the two, rofecoxib was much better at blocking COX-2 specifically, and thus far less likely to cause stomach ulcers.
After a few years on the market, signals started to appear that rofecoxib was associated with a heavily increased risk of heart attack and stroke. In fact, people taking rofecoxib had something like a 300% increased risk of having a heart attack compared with people taking non-selective NSAID’s. Merck’s initial response was, unsurprisingly, to try to put the lid on this information. But by 2004, the cat was well and truly out of the bag. In the face of mounting criticism (and lawsuits), Merck chose to withdraw the drug from the market. By that point, 80 million people had been treated with rofecoxib and around 100,000 people had suffered unnecessary heart attacks.”
CDC OPIOID GUIDELINES KILL
RICHARD LAWHERN PH.D:
“ The agency has single-handedly wrecked the practice of pain medicine throughout the US, and is directly responsible for tens of thousands of suicides among patients who are actively being denied pain care because of its profound policy misdirection and outright malfeasance and malpractice.
And the February 10, 2022 “update” and expansion of its 2016 opioid guidelines are guaranteed to make a horrid situation even worse.
Writing as a subject matter expert in public policy for the regulation of prescription opioids and of clinicians who employ them, I have done a deep dive into the 211-page draft “revised” CDC guidelines. I characterize the draft as “A Little Shop of Horrors, Version 2.0”. The supposed “improvements” identified by AMA and this article are illusory.
Congress must direct the CDC to cease, halt, and desist from generating “guidelines” for any branch of medical practice other than communicable disease. CDC and its public health “experts” have never treated patients in pain. They have neither the expertise nor the moral compass to direct treatment decisions between real doctors and their patients.”
FOR, NOW YOU ARE WITHIN